Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT07386626

Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection

Led by Tongji Hospital · Updated on 2026-04-08

118

Participants Needed

1

Research Sites

45 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Combining tegileridine PCIA with ICNB targeting peripheral nerves, may constitute an ideal analgesic model with complementary advantages. Thus potentially achieving the analgesic goal of "early pain relief, stable throughout the process, and rapid recovery," and may have a positive impact on reducing CPSP.

CONDITIONS

Official Title

Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 75 years
  • Undergoing elective thoracoscopic lobectomy or segmentectomy
  • ASA classification I to III
  • Body mass index (BMI) between 18 and 30 kg/m2
  • Voluntary participation with signed informed consent
Not Eligible

You will not qualify if you...

  • Preoperative alcohol dependence or long-term use of analgesic drugs for other pain
  • Pregnant or lactating women
  • Allergies or contraindications to anesthetics, analgesics, or antiemetic drugs used in this study
  • Severe sleep apnea syndrome or acute/severe bronchial asthma
  • Mental or neurological disorders, cognitive impairment, gastrointestinal obstruction
  • Severe liver or kidney dysfunction (Child Pugh score C)
  • Chronic obstructive pulmonary disease or severe cardiovascular disease
  • Any condition deemed unsuitable by researchers or refusal to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tongji hospital

Wuhan, Hubei, China, 430030

Actively Recruiting

Loading map...

Research Team

A

Aijun Xu, Dr.

CONTACT

H

Hongbo Zheng, Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here